Drug-drug interactions: it is not only CYP450's which matter

被引：0
|
作者：
Back, David J. [1 ]
机构：
[1] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
来源：
RETROVIROLOGY | 2010年 / 7卷
关键词：
Therapeutic Drug Monitoring; CYP450 Enzyme; Drug Disposition; Pharmacokinetic Drug; Sheer Number;
D O I：
10.1186/1742-4690-7-S1-I10
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：4 / 4
页数：1
相关论文
共 50 条
  • [31] Brivanib Exhibits Potential for Pharmacokinetic Drug-Drug Interactions and the Modulation of Multidrug Resistance through the Inhibition of Human ABCG2 Drug Efflux Transporter and CYP450 Biotransformation Enzymes
    Hofman, Jakub
    Sorf, Ales
    Vagiannis, Dimitrios
    Sucha, Simona
    Kammerer, Sarah
    Kuepper, Jan-Heiner
    Chen, Si
    Guo, Lei
    Ceckova, Martina
    Staud, Frantisek
    MOLECULAR PHARMACEUTICS, 2019, 16 (11) : 4436 - 4450
  • [32] DRUG-DRUG INTERACTIONS ASSOCIATED WITH MULTI-CYP INHIBITORS
    Hachad, H.
    Ragueneau-Majlessi, I.
    Levy, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S29 - S30
  • [33] CYP-associated drug-drug interactions: A mission accomplished?
    Pelkonen, Olavi
    Hakkola, Jukka
    Hukkanen, Janne
    Turpeinen, Miia
    ARCHIVES OF TOXICOLOGY, 2020, 94 (11) : 3931 - 3934
  • [34] CYP450 MEDIATED DRUG METABOLISM IN HUMAN LUNG TISSUE
    Gravel, Sophie
    Huguet, Jade
    Rousseau, Eric
    Gaudette, Fleur
    Turgeon, Jacques
    Michaud, Veronique
    DRUG METABOLISM REVIEWS, 2015, 47 : 139 - 139
  • [35] CYP450 Genotyping and Clinical Response to Psychotropic Drug Treatment
    Mrazek, David A.
    BIOLOGICAL PSYCHIATRY, 2009, 65 (08) : 103S - 103S
  • [36] Drug-Drug Interaction Potential of Remimazolam: CYP 450, Transporters, and Protein Binding
    Petersen, Karl-Uwe
    Schmalix, Wolfgang
    Pesic, Marija
    Stoehr, Thomas
    CURRENT DRUG METABOLISM, 2024, 25 (04) : 266 - 275
  • [37] A DRUG-DRUG INTERACTION STUDY INVESTIGATING THE EFFECT OF GIVOSIRAN ON ACTIVITY OF FIVE DRUG METABOLIZING CYP450 ENZYMES IN ACUTE HEPATIC PORPHYRIA (AHP) PATIENTS.
    Agarwal, S.
    Sardh, E.
    Harper, P.
    Vassiliou, D.
    Simon, A.
    Robbie, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S59 - S59
  • [38] Doravirine and the Potential for CYP3A-Mediated Drug-Drug Interactions
    Khalilieh, Sauzanne G.
    Yee, Ka Lai
    Sanchez, Rosa I.
    Fan, Li
    Anderson, Matt S.
    Sura, Monali
    Laethem, Tine
    Rasmussen, Scott
    van Bortel, Luc
    van Lancker, Griet
    Iwamoto, Marian
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (05)
  • [39] Drug-drug interactions and the cytochrome P450 system: An update
    Shannon, M
    PEDIATRIC EMERGENCY CARE, 1997, 13 (05) : 350 - 353
  • [40] Mechanism of Drug-Drug Interactions Mediated by Human Cytochrome P450 CYP3A4 Monomer
    Denisov, Ilia G.
    Grinkova, Yelena V.
    Baylon, Javier L.
    Tajkhorshid, Emad
    Sligar, Stephen G.
    BIOCHEMISTRY, 2015, 54 (13) : 2227 - 2239
12345